Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death

Immunity

Volumn 29, Issue 2, 2008, Pages 283-294

  Clay, Hilary ^a   Volkman, Hannah E ^a   Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CELLIMMUNO

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL DEATH; CONTROLLED STUDY; EMBRYO; GRANULOMA; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; INFECTION RESISTANCE; INNATE IMMUNITY; MACROPHAGE; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM MARINUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ZEBRA FISH;

ANIMALS; APOPTOSIS; CELL DEATH; CELL MOVEMENT; CYTOKINES; EMBRYO, NONMAMMALIAN; GRANULOMA; IMMUNITY, NATURAL; MACROPHAGES; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS; ZEBRAFISH;

EID: 48749114458     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.06.011     Document Type: Article

References (87)

1. Adams L.B., Dinauer M.C., Morgenstern D.E., and Krahenbuhl J.L. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78 (1997) 237-246
2. Algood H.M., Lin P.L., and Flynn J.L. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin. Infect. Dis. 41 Suppl 3 (2005) S189-S193
3. Appelberg R., Castro A.G., Pedrosa J., Silva R.A., Orme I.M., and Minoprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62 (1994) 3962-3971
4. Armstrong J.A., and Hart P.D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134 (1971) 713-740
5. Bates J.M., Akerlund J., Mittge E., and Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe (2007) in press
6. Bean A.G., Roach D.R., Briscoe H., France M.P., Korner H., Sedgwick J.D., and Britton W.J. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162 (1999) 3504-3511
7. Bekker L.G., Moreira A.L., Bergtold A., Freeman S., Ryffel B., and Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 68 (2000) 6954-6961
8. Benini J., Ehlers E.M., and Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J. Pathol. 189 (1999) 127-137
9. Berrington W.R., and Hawn T.R. Mycobacterium tuberculosis, macrophages, and the innate immune response: Does common variation matter?. Immunol. Rev. 219 (2007) 167-186
10. Bhatt A., Fujiwara N., Bhatt K., Gurcha S.S., Kremer L., Chen B., Chan J., Porcelli S.A., Kobayashi K., Besra G.S., and Jacobs Jr. W.R. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. USA 104 (2007) 5157-5162
11. Botha T., and Ryffel B. Reactivation of latent tuberculosis infection in TNF-deficient mice. J. Immunol. 171 (2003) 3110-3118
12. Broker L.E., Kruyt F.A., and Giaccone G. Cell death independent of caspases: A review. Clin. Cancer Res. 11 (2005) 3155-3162
13. Chakravarty S.D., Zhu G., Tsai M.C., Mohan V.P., Marino S., Kirschner D.E., Huang L., Flynn J., and Chan J. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76 (2008) 916-926
14. Clay H., Davis J.M., Beery D., Huttenlocher A., Lyons S.E., and Ramakrishnan L. Dichotomous role of the macrophage in early mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2 (2007) 29-39
15. Clay H., and Ramakrishnan L. Multiplex Fluorescent in situ hybridization in zebrafish embryos using tyramide signal amplification. Zebrafish 2 (2005) 105-111
16. Cosma C.L., Klein K., Kim R., Beery D., and Ramakrishnan L. Mycobacterium marinum Erp is a virulence determinant required for cell wall integrity and intracellular survival. Infect. Immun. 74 (2006) 3125-3133
17. Cosma C.L., Sherman D.R., and Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57 (2003) 641-676
18. Criscione L.G., and St Clair E.W. Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. Curr. Opin. Rheumatol. 14 (2002) 204-211
19. Dannenberg Jr. A.M. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. (Off. Ed.) 28 (1993) 51-58
20. Darzins E., and Fahr G. Cord-forming property, lethality and pathogenicity of Mycobacteria. Dis. Chest 30 (1956) 642-648
21. Davis J.M., Clay H., Lewis J.L., Ghori N., Herbomel P., and Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17 (2002) 693-702
22. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988) 2407-2412
23. Draper B.W., Morcos P.A., and Kimmel C.B. Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: A quantifiable method for gene knockdown. Genesis 30 (2001) 154-156
24. Dubos R.J., and Pierce C.H. Differential characteristics in vitro and in vivo of several substrains of BCG. II. Morphologic characteristics in vitro and in vivo. Am. Rev. Tuberc. 74 (1956) 667-682
25. Egen J.G., Rothfuchs A.G., Feng C.G., Winter N., Sher A., and Germain R.N. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28 (2008) 271-284
26. Ehlers S., Benini J., Kutsch S., Endres R., Rietschel E.T., and Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 67 (1999) 3571-3579
27. Ehlers S., Kutsch S., Ehlers E.M., Benini J., and Pfeffer K. Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/- mice is dependent on T cells and IL-12. J. Immunol. 165 (2000) 483-492
28. Engele M., Stossel E., Castiglione K., Schwerdtner N., Wagner M., Bolcskei P., Rollinghoff M., and Stenger S. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 168 (2002) 1328-1337
29. Flesch I.E., Hess J.H., Oswald I.P., and Kaufmann S.H. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6 (1994) 693-700
30. Flesch I.E., and Kaufmann S.H. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58 (1990) 2675-2677
31. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
32. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., and Bloom B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
33. Fratazzi C., Arbeit R.D., Carini C., Balcewicz-Sablinska M.K., Keane J., Kornfeld H., and Remold H.G. Macrophage apoptosis in mycobacterial infections. J. Leukoc. Biol. 66 (1999) 763-764
34. Garcia Vidal C., Rodriguez Fernandez S., Martinez Lacasa J., Salavert M., Vidal R., Rodriguez Carballeira M., and Garau J. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin. Infect. Dis. 40 (2005) 756-759
35. Gardam M.A., Keystone E.C., Menzies R., Manners S., Skamene E., Long R., and Vinh D.C. Anti-tumour necrosis factor agents and tuberculosis risk: Mechanisms of action and clinical management. Lancet Infect. Dis. 3 (2003) 148-155
36. Glickman M.S., Cox J.S., and Jacobs Jr. W.R. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5 (2000) 717-727
37. Gomez-Reino J.J., Carmona L., and Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum. 57 (2007) 756-761
38. Guinn K.M., Hickey M.J., Mathur S.K., Zakel K.L., Grotzke J.E., Lewinsohn D.M., Smith S., and Sherman D.R. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51 (2004) 359-370
39. Herbomel P., Thisse B., and Thisse C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 126 (1999) 3735-3745
40. Herbomel P., Thisse B., and Thisse C. Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptor-dependent invasive process. Dev. Biol. 238 (2001) 274-288
41. Hernandez R.E., Rikhof H.A., Bachmann R., and Moens C.B. vhnf1 integrates global RA patterning and local FGF signals to direct posterior hindbrain development in zebrafish. Development 131 (2004) 4511-4520
42. Hsu T., Hingley-Wilson S.M., Chen B., Chen M., Dai A.Z., Morin P.M., Marks C.B., Padiyar J., Goulding C., Gingery M., et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. USA 100 (2003) 12420-12425
43. Huerta S., Goulet E.J., Huerta-Yepez S., and Livingston E.H. Screening and detection of apoptosis. J. Surg. Res. 139 (2007) 143-156
44. Iliopoulos A., Psathakis K., Aslanidis S., Skagias L., and Sfikakis P.P. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int. J. Tuberc. Lung Dis. 10 (2006) 588-590
45. Kaku T., Kawamura I., Uchiyama R., Kurenuma T., and Mitsuyama M. RD1 region in mycobacterial genome is involved in the induction of necrosis in infected RAW264 cells via mitochondrial membrane damage and ATP depletion. FEMS Microbiol. Lett. 274 (2007) 189-195
46. Kaneko H., Yamada H., Mizuno S., Udagawa T., Kazumi Y., Sekikawa K., and Sugawara I. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. Lab. Invest. 79 (1999) 379-386
47. Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat. Med. 6 (2000) 955-960
48. Keane J. TNF-blocking agents and tuberculosis: New drugs illuminate an old topic. Rheumatology (Oxford) 44 (2005) 714-720
49. Kindler V., Sappino A.P., Grau G.E., Piguet P.F., and Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56 (1989) 731-740
50. Koch R. The Aetiology of Tuberculosis (1882), National Tuberculosis Association, New York
51. Kwon O.J. The role of nitric oxide in the immune response of tuberculosis. J. Korean Med. Sci. 12 (1997) 481-487
52. Lange C., Hellmich B., Ernst M., and Ehlers S. Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy. Nat. Clin. Pract. Rheumatol. 3 (2007) 528-534
53. Lawn S.D., Butera S.T., and Shinnick T.M. Tuberculosis unleashed: The impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect. 4 (2002) 635-646
54. Lee J., Remold H.G., Ieong M.H., and Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176 (2006) 4267-4274
55. Lin P.L., Plessner H.L., Voitenok N.N., and Flynn J.L. Tumor necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc. 12 (2007) 22-25
56. Liu N., Raja S.M., Zazzeroni F., Metkar S.S., Shah R., Zhang M., Wang Y., Bromme D., Russin W.A., Lee J.C., et al. NF-kappaB protects from the lysosomal pathway of cell death. EMBO J. 22 (2003) 5313-5322
57. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
58. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104 (2001) 487-501
59. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., and Wilkinson R.J. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37. J. Immunol. 178 (2007) 7190-7198
60. Menendez A., and Brett Finlay B. Defensins in the immunology of bacterial infections. Curr. Opin. Immunol. 19 (2007) 385-391
61. Middlebrook G., Dubos R.J., and Pierce C. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 86 (1947) 175-184
62. Miyakawa Y., Ratnakar P., Rao A.G., Costello M.L., Mathieu-Costello O., Lehrer R.I., and Catanzaro A. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64 (1996) 926-932
63. Mohan V.P., Scanga C.A., Yu K., Scott H.M., Tanaka K.E., Tsang E., Tsai M.M., Flynn J.L., and Chan J. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology. Infect. Immun. 69 (2001) 1847-1855
64. O'Sullivan M.P., O'Leary S., Kelly D.M., and Keane J. A caspase-independent pathway mediates macrophage cell death in response to Mycobacterium tuberculosis infection. Infect. Immun. 75 (2007) 1984-1993
65. Pan H., Yan B.S., Rojas M., Shebzukhov Y.V., Zhou H., Kobzik L., Higgins D.E., Daly M.J., Bloom B.R., and Kramnik I. Ipr1 gene mediates innate immunity to tuberculosis. Nature 434 (2005) 767-772
66. Parichy D.M., Ransom D.G., Paw B., Zon L.I., and Johnson S.L. An orthologue of the kit-related gene fms is required for development of neural crest-derived xanthophores and a subpopulation of adult melanocytes in the zebrafish, Danio rerio. Development 127 (2000) 3031-3044
67. Pressley M.E., Phelan III P.E., Witten P.E., Mellon M.T., and Kim C.H. Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebrafish. Dev. Comp. Immunol. 29 (2005) 501-513
68. Roach D.R., Bean A.G., Demangel C., France M.P., Briscoe H., and Britton W.J. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168 (2002) 4620-4627
69. Rojo I., de Ilarduya O.M., Estonba A., and Pardo M.A. Innate immune gene expression in individual zebrafish after Listonella anguillarum inoculation. Fish Shellfish Immunol. 23 (2007) 1285-1293
70. Shin D.H., Lim H.S., Cho S.K., Lee H.Y., Lee H.W., Lee K.H., Chung Y.H., Cho S.S., Ik Cha C., and Hwang D.H. Immunocytochemical localization of neuronal and inducible nitric oxide synthase in the retina of zebrafish, Brachydanio rerio. Neurosci. Lett. 292 (2000) 220-222
71. Smith S., Liggitt D., Jeromsky E., Tan X., Skerrett S.J., and Wilson C.B. Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect. Immun. 70 (2002) 2082-2089
72. Stamm L.M., Morisaki J.H., Gao L.Y., Jeng R.L., McDonald K.L., Roth R., Takeshita S., Heuser J., Welch M.D., and Brown E.J. Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J. Exp. Med. 198 (2003) 1361-1368
73. Stenger S. Immunological control of tuberculosis: Role of tumour necrosis factor and more. Ann. Rheum. Dis. 64 Suppl 4 (2005) iv24-iv28
74. Stinear T.P., Seemann T., Harrison P.F., Jenkin G.A., Davies J.K., Johnson P.D., Abdellah Z., Arrowsmith C., Chillingworth T., Churcher C., et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 18 (2008) 729-741
75. Swaim L.E., Connolly L.E., Volkman H.E., Humbert O., Born D.E., and Ramakrishnan L. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect. Immun. 74 (2006) 6108-6117
76. Taylor J.C., Orkin R., and Lanham J. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy. Rheumatology (Oxford) 42 (2003) 901-902
77. Tobin D.M., and Ramakrishnan L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell. Microbiol. 10 (2008) 1027-1039
78. Tosh K., Campbell S.J., Fielding K., Sillah J., Bah B., Gustafson P., Manneh K., Lisse I., Sirugo G., Bennett S., et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc. Natl. Acad. Sci. USA 103 (2006) 10364-10368
79. Traver D., Herbomel P., Patton E.E., Murphey R.D., Yoder J.A., Litman G.W., Catic A., Amemiya C.T., Zon L.I., and Trede N.S. The zebrafish as a model organism to study development of the immune system. Adv. Immunol. 81 (2003) 253-330
80. Trede N.S., Langenau D.M., Traver D., Look A.T., and Zon L.I. The use of zebrafish to understand immunity. Immunity 20 (2004) 367-379
81. Ulrichs T., and Kaufmann S.H. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208 (2006) 261-269
82. van Crevel R., Ottenhoff T.H., and van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15 (2002) 294-309
83. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10 (1992) 411-452
84. Vlachaki E., Psathakis K., Tsintiris K., and Iliopoulos A. Delayed response to anti-tuberculosis treatment in a patient on infliximab. Respir. Med. 99 (2005) 648-652
85. Volkman H.E., Clay H., Beery D., Chang J.C., Sherman D.R., and Ramakrishnan L. Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol. 2 (2004) e367
86. Wagner T.E., Huseby E.S., and Huseby J.S. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor. Am. J. Med. 112 (2002) 67-69
87. Zganiacz A., Santosuosso M., Wang J., Yang T., Chen L., Anzulovic M., Alexander S., Gicquel B., Wan Y., Bramson J., et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113 (2004) 401-413